RxDoctor Payments Data

Lisa Baumann Kreuziger, MD

Hematology & Oncology · Milwaukee, WINPI 1831316678

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $6,655 of the $8,274 with a category attached, or 80.4%. Every reported general payment came from a single manufacturer, CSL Behring.

$8,274in general payments, 2019–2025

Across 8 payments — averaging $1034.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$8K
$181,305in research payments, 2019–2025

Across 33 payments — averaging $5494.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$109K
  • Sanofi$72K

What the payments were for

  • Speaking & faculty fees$6,65580%
  • Travel & lodging$1,37617%
  • Food & beverage$2423%

General payments by program year

19
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring8$8,274

How this compares

$8,274 in reported general payments places this provider in the 75th percentile of 248 hematology & oncology providers in Wisconsin.

See all hematology & oncology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$17,082
Medicare patients
112
Services billed
170

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban158$143,110
XareltoRivaroxaban90$82,885
Enoxaparin Sodium19$7,375
Hydroxyurea43$788
Warfarin Sodium81$778

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →